健脾滋肾法治疗系统性红斑狼疮有效性及安全性的Meta分析
Efficacy and Safety of Spleen Invigorating and Kidney Nourishing Therapy in the Treatment of Systemic Lupus Erythematosus
摘要: 目的：系统评价健脾滋肾法治疗系统性红斑狼疮的有效性及安全性。方法：计算机检索中国知网(CNKI)、维普中文科技期刊全文数据库(VIP)、万方数据资源系统(Wan Fang Data)、PubMed、Cochrane Library、Web of Science、Springer数据库中健脾滋肾法治疗系统性红斑狼疮的随机对照临床试验文献，以“健脾滋肾法”“健脾益肾法”和“系统性红斑狼疮”为并列检索词。并对文献进行质量评价、数据提取，用Review Manger 5.3软件进行Meta分析，评估健脾滋肾法治疗系统性红斑狼疮的有效性及安全性。结果：最终有10个随机对照临床试验纳入研究，累计观察系统性红斑狼疮患者598例，总有效率的Meta分析结果显示，RR = 1.11, 95%CI [1.03, 1.19], Z = 2.67, P < 0.05；SLEDAI评分的Meta分析结果显示MD = −0.58, 95%CI [−0.87, −0.30], Z = 4, P < 0.05。结论：健脾滋肾法联合激素治疗系统性红斑狼疮可以提高临床疗效并具有安全性。
Abstract: Objective: To systematically evaluate the efficacy and safety of spleen invigorating and kidney nourishing therapy in the treatment of systemic lupus erythematosus. Methods: The randomized controlled clinical trial literature of spleen invigorating and kidney nourishing therapy for sys-temic lupus erythematosus in CNKI, VIP, Wan Fang data and PubMed databases were searched by computer. The keywords were “spleen invigorating and kidney nourishing therapy”, “spleen invigorating and kidney nourishing therapy” and “systemic lupus erythematosus”. The quality evaluation and data extraction of the literature were carried out, and meta-analysis was carried out with review manger 5.3 software to evaluate the effectiveness and safety of spleen invigorating and kidney nourishing therapy in the treatment of systemic lupus erythematosus. Results: Ten randomized controlled clinical trials were finally included in the study. A total of 598 patients with systemic lupus erythematosus were observed. The meta-analysis results of the total effective rate showed that RR = 1.11, 95%CI [1.03, 1.19], Z = 2.67, P < 0.05; The meta-analysis results of SLEDAI score showed that MD = −0.58, 95%CI [−0.87, −0.30], Z = 4, P < 0.05. Conclusion: Spleen invigorating and kidney nourishing therapy combined with hormone in the treatment of systemic lupus erythematosus can improve the clinical efficacy and safety.
文章引用：潘承丹, 魏方志, 宫爱民, 张绚, 宋逸天. 健脾滋肾法治疗系统性红斑狼疮有效性及安全性的Meta分析[J]. 中医学, 2023, 12(1): 189-198. https://doi.org/10.12677/TCM.2023.121031

参考文献

[1] Costenbader, K.H., Feskanich, D., Stampfer, M.J. and Karlson, E.W. (2007) Reproductive and Menopausal Factors and Risk of Systemic Lupus Erythematosus in Women. Arthritis & Rheumatism, 56, 1251-1262. [Google Scholar] [CrossRef] [PubMed]
[2] 林丽, 万春平, 李小丝, 等. 益气养阴补肾方联合激素对自发狼疮转基因小鼠增效减毒作用的研究[J]. 时珍国医国药, 2017, 28(5): 1044-1046.
[3] 龚晓红, 李松伟, 李桓, 等. 青蒿鳖甲汤化裁治疗阴虚型系统性红斑狼疮增效减毒的Meta分析[J]. 风湿病与关节炎, 2020, 9(9): 33-38+42.
[4] 陈薇薇, 苏励, 苏晓, 夏嘉. 当代医家中医药辨治系统性红斑狼疮的思路和方法[J]. 中华中医药学刊, 2019, 37(4): 922-924.
[5] Hochberg, M.C. (1997) Updating the American College of Rheumatology Revised Criteria for the Classification of Systemic Lupus Erythematosus. Arthritis & Rheumatism, 40, 1725. [Google Scholar] [CrossRef] [PubMed]
[6] 陶桢珍. 健脾滋肾法对SLE临床疗效及激素减撤作用机制研究[D]: [硕士学位论文]. 合肥: 安徽中医药大学, 2020.
[7] 刘思娣, 黄传兵, 石周珍, 朱刚. 健脾滋肾法对脾肾两虚型SLE疾病活动影响的研究[J]. 江西中医药大学学报, 2020, 32(1): 35-39.
[8] 王文静. 健脾滋肾法对系统性红斑狼疮患者血清ACTH和皮质醇影响的临床研究[D]: [硕士学位论文]. 合肥: 安徽中医药大学, 2018.
[9] 杨小静, 黄传兵, 刘轶菲, 等. 健脾滋肾法对系统性红斑狼疮的疗效及患者生活质量的影响[J]. 北京中医药大学学报, 2016, 39(1): 77-81.
[10] 武敏, 黄传兵, 贾建云, 等. 健脾滋肾法治疗脾肾两虚型缓解期系统性红斑狼疮疗效研究[J]. 新中医, 2015, 47(10): 70-72.
[11] 陈蕾蕾. 健脾滋肾法对SLE疾病活动与外周血TLR7/9表达水平影响的研究[D]: [硕士学位论文]. 合肥: 安徽中医药大学, 2021.
[12] 黄娟. 健脾益肾方联合西药治疗气阴两虚夹瘀型狼疮性肾炎的临床研究[D]: [硕士学位论文]. 南宁: 广西中医药大学, 2017.
[13] 付俊. 健脾滋肾法对SLE患者骨转换标志物及血清25(OH)D3水平影响的临床研究[D]: [硕士学位论文]. 合肥: 安徽中医药大学, 2017.
[14] 刘轶菲. 健脾滋肾法对系统性红斑狼疮的疗效及免疫学机制研究[D]: [硕士学位论文]. 合肥: 安徽中医药大学, 2014.
[15] 王泽, 黄传兵, 陈君洁, 等. 健脾滋肾方对脾肾阳虚型系统性红斑狼疮疾病活动的影响[J]. 安徽中医药大学学报, 2022, 41(1): 17-21.
[16] 王志远, 王梦洁, 王莹, 崔炎. 白芍总苷治疗系统性红斑狼疮有效性及安全性的Meta分析[J]. 中药药理与临床, 2022, 38(3): 146-151.
[17] 刘长宁, 张立娟, 侯翰如, 等. 中成药治疗阿尔茨海默病的网状Meta分析[J]. 中草药, 2022, 53(19): 6123-6138.